Vitamin K Deficiency at Birth Linked to Higher Risk of Brain Bleeding

Infants in Sweden who do not receive intramuscular vitamin K at birth face a significantly higher risk of bleeding complications, including intracranial hemorrhage, according to a nationwide cohort study published in JAMA Pediatrics. Research tracking more than 2 million live births between 2003 and 2021 found that infants without vitamin K prophylaxis had 1.52 times the odds of any bleeding episode and 2.91 times the odds of intracranial bleeding during their first six months of life.

The Growing Trend of Parental Refusal

While the vast majority of newborns receive the standard vitamin K shot, researchers at the Karolinska Institutet in Stockholm identified a concerning shift in parental behavior. After an initial decline in refusal rates during the early 2000s, the trend reversed. By 2021, the rate of nonreceipt had climbed to 1.50%, or 1,619 infants out of 107,915 births.

Lead researcher Eleni Simatou, MD, and her colleagues noted that this uptick mirrors recent challenges seen with childhood vaccinations. As parental skepticism grows, medical professionals are tasked with better communicating the biological necessity of the supplement. Infants are naturally vulnerable to vitamin K deficiency bleeding (VKDB) because the vitamin does not easily cross the placenta and is found in low concentrations in breast milk. Furthermore, a newborn’s developing gut flora, such as Lactobacillus, is not yet capable of synthesizing the vitamin independently.

Intramuscular vs. Oral Administration

While some parents choose oral vitamin K when they refuse the intramuscular injection, the data suggests this alternative may offer less protection. Infants who received oral vitamin K had 2.26 times the odds of any bleeding episode compared to those who received the injection. For bleeding within the first 28 days of life, the odds were 3.74 times higher for the oral group.

In the Swedish clinical setting, oral administration is typically reserved only for cases where the injection is impossible, such as diagnosed hemophilia or specific parental refusals. The study confirms that the standard intramuscular approach remains the most effective clinical safeguard against VKDB.

Why Geography and Culture Matter

Researchers examined whether specific infant characteristics influenced the likelihood of receiving the shot. Unlike in the United States, where studies have previously linked male sex to higher rates of vitamin K receipt, the Swedish cohort showed no such disparity. Simatou and her team attribute this to differing cultural practices, specifically circumcision.

In many U.S. settings, medical documentation of vitamin K prophylaxis is often required prior to circumcision. Because circumcision is uncommon in Sweden, this administrative driver does not influence parental decisions or clinical protocols in the same way. This finding underscores how local healthcare policies and elective procedures can inadvertently shape public health outcomes.

Study Limitations

• Data Classification: The researchers noted potential for misclassification in electronic medical records.
• Confounding Factors: The study could not fully adjust for external variables like maternal substance use, specific medications, or breastfeeding patterns.
• Observational Nature: As a cohort study, it demonstrates a strong association but cannot definitively prove a singular causal pathway for every case.

Frequently Asked Questions

Why is vitamin K given at birth?
Newborns are born with low levels of vitamin K, which is necessary for blood clotting. A shot at birth prevents vitamin K deficiency bleeding (VKDB), which can cause serious internal or brain hemorrhages.

Is oral vitamin K as effective as the shot?
According to the JAMA Pediatrics study, infants who received oral vitamin K had significantly higher odds of bleeding episodes compared to those who received the intramuscular injection.

Are refusal rates increasing globally?
Yes. The researchers noted that several countries have reported rising trends of parental refusal for vitamin K, which has been followed by a subsequent increase in documented cases of VKDB.